Photo: isbtweb.org
Mar 3, 2026, 14:21
Webinar on CAR-T Cells – Heterogeneity, Quality Control, and Adverse Events – ISBT
International Society of Blood Transfusion (ISBT) shared a post on LinkedIn:
“ISBT Webinar: Let’s talk CAR-T cells – heterogeneity, quality control and adverse events.
4 March 2026 | 17:00–18:00 CET
Join Oulghazi Salim for an accessible introduction to CAR-T cell therapy, covering clinical applications, cellular heterogeneity, quality control advances, and associated adverse events.
Ideal for scientists, transfusion professionals, MDs, and MSc/PhD students.
Register now and be part of the conversation”
Stay updated with Hemostasis Today.
-
Apr 22, 2026, 11:47We Are Excited to Introduce You to the 11th Editor-in-Chief Dr. Bob Löwenberg – Blood Journals Portfolio
-
Apr 22, 2026, 11:35Congratulations to Donald Arnold for Being Recognized with The ISTH 2026 Harold R. Roberts Award
-
Apr 22, 2026, 11:27Prashasti Dahiya: Key Molecular Insights on Thromboinflammation and Angiogenesis in Pediatric Cancer
-
Apr 22, 2026, 11:17Jack Hadfield: Understanding the Immune and Genetic Basis of VITT Post-COVID Vaccines
-
Apr 22, 2026, 07:56Shruti Kharat: Closing the Gap in Early Detection of Factor VIII Inhibitors
-
Apr 22, 2026, 07:46Gregory Piazza: Ushering in a New Era in PE Therapy and Improved Clinical Outcomes for Our Patients
-
Apr 22, 2026, 07:40Akshat Jain: WIL33 Study Advances Factor Prophylaxis in Children with von Willebrand Disease
-
Apr 22, 2026, 07:36Selma Turkovic: Blood Transfusion Education and Discussion Group Webinar 61
-
Apr 22, 2026, 07:34Aikati Anastasiou: Advancing Stroke Imaging Insights from the DISTAL Trial